Covid-19: Axio Biosolutions launches hand sanitizers and surgical disinfectants under RESIST+ brand to meet rising demand

By / 3 months ago / News Update / No Comments
Covid-19: Axio Biosolutions launches hand sanitizers and surgical disinfectants under RESIST+ brand to meet rising demand
  • Company to expand capacity to 100,000 litres in the coming days and also launch protective gears for frontline healthcare professionals
  • Part of the proceeds will go to the PM CARES Fund and hospitals

Responding to Prime Minister Narendra Modi’s appeal to startups and entrepreneurs to come forward with innovative solutions to help combat the COVID-19 challenge, Axio Biosolutions has launched RESIST+, a hygiene and protection range to meet the growing demand due to the current pandemic. Funded by Ratan Tata’s UC RNT, Omidyar Network and other investors, the startup has rolled out surgical hand disinfectants and hand sanitizers with a running capacity of 25,000 litres at present. The plan is to expand the capacity to 100,000 litres in the coming days.

As India’s leading advanced woundcare company, the Bengaluru based startup, with its manufacturing plant in Ahmedabad, is determined to help the country build its own arsenal to fight the coronavirus crisis. The new product range, manufactured in compliance with WHO standards and Pharma regulations, will soon include masks and other protective gear.

Commenting on the rationale behind RESIST+, Leo Mavely, Founder & CEO, Axio Biosolutions, said, “For India to tackle the pandemic, we need to address the large-scale shortage of quality hygiene and safety products. Hospitals are getting overwhelmed with deluge of patients and the dearth of quality products is a challenge. People are forced to procure sanitizers and disinfectants from various unvetted non-medical sources. The need of the hour is for medtech companies is to support in every way they can. At Axio, our priority is to meet the urgent demands from hospitals and institutions in India, followed by other regions.”  

Funded by Ratan Tata’s UC RNT, Omidyar Network, Accel and Chiratae Ventures, Axio is India’s leading medtech company that has been at the forefront the global advanced wound care and surgical market. With its foray into the hygiene and protection range with RESIST+, the company is determined to help India win the battle against the coronavirus. This may also become a permanent consumer product line with more innovative hygiene products with proprietary formula to be added under the brand RESIST+ 

The World Health Organization (WHO) recommends using hand sanitizers and disinfectants with at least 60 per cent alcohol content for greater efficacy. Resist + hand sanitizer contains 70 per cent alcohol, while Resist + surgical hand disinfectant contains 75 per cent alcohol. Currently Axio is ramping up their supply chain during the lockdown with support from local government to get their products to major cities.

admin

The author didn't add any Information to his profile yet.